support at 89, page-18

back to basics vcr is now a company with a earnings potential; the value is now mathetically calculable and the finite figure according to the abn amro analyst is $1.30. biotech funds will rerate this co on a/c of its ce mark approval(alternatively known as a permit to print euros).

be patient to be rewarded even before that permit to print greenbacks comes about.